Electrostatic reversal of serine proteinase substrate specificity

Proteins: Structure, Function and Genetics

Volumn 35, Issue 4, 1999, Pages 415-424

  Caputo, Antonio ^a   Parrish, Jonathan C ^a   James, Michael N G ^a   Powers, James C ^b   Bleackley, R Chris ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Granzyme B; Molecular modeling; Mutagenesis

Indexed keywords

GRANZYME B; SERINE PROTEINASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ELECTRICITY; ENZYME SPECIFICITY; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0033151922     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(19990601)35:4<415::AID-PROT5>3.0.CO;2-7     Document Type: Article

References (51)

1. Smyth MJ, O'Connor MD, Trapani JA. Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies. J Leuk Biol 1996;60:555-562.
2. Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 1967;27:157-162.
3. Caughey GH, Schaumberg TH, Zerweck EH et al. The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics 1993;15:614-620.
4. Gurish MF, Nadeau JH, Johnson KR et al. A closely linked complex of mouse mast cell-specific chymase genes on chromosome 14. J Biol Chem 1993;268:11372-11379.
5. Yoshida N, Everitt MT, Neurath H, Woodbury RG, Powers JC. Substrate specificity of two chymotrypsin-like proteases from rat mast cells. Studies with peptide 4-nitroanilides and comparison with cathepsin G. Biochemistry 1980;19:5799-5804.
6. Odake S, Kam CM, Narasimhan L et al. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry 1991;30:2217-2227.
7. Trapani JA, Smyth MJ. Killing by cytotxic T cells and natural killer cells: multiple granule serine proteases as initiators of DNA fragmentation. Immunol Cell Biol 1993;71:201-208.
8. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994;76:977-987.
9. Shi L, Kraut RP, Aebersold R, Greenberg AH. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 1992;175:553-566.
10. Shi L, Mai S, Israels S, Browne K, Trapani JA, Greenberg AH. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. J Exp Med 1997;185:855-866.
11. Jans DA, Jans P, Briggs LJ, Sutton V, Trapani JA. Nuclear transport of granzyme B (fragmentin-2). Dependence of perforin in vivo and cytosolic factors in vitro. J Biol Chem 1996;271:30781-30789.
12. Nakajima H, Park HL, Henkart PA. Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. J Exp Med 1995;181:1037-1046.
13. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316.
14. Green, DR. Apoptotic pathways: the roads to ruin. Cell 1998;94: 695-698.
15. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 1998;273:2926-2930.
16. Martin DA, Siegel RM, Zheng L, Lenardo MJ. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHα1) death signal. J Biol Chem 1998;273:4345-4349.
17. Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995;377:446-448.
18. Duan H, Orth K, Chinnaiyan AM et al. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 1996;271:16720-16724.
19. Orth K, Chinnayan AM, Garg M, Froelich CJ, Dixit VM. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem 1996;271:16443-16446.
20. Fernandes-Alnemri T, Armstrong RC, Krebs J et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci 1996;93:7464-7469.
21. Gu Y, Sarnecki C, Fleming MA, Lippke JA, Bleackley RC, Su MS. Processing and activation of CMH-1 by granzyme B. J Biol Chem 1996;271:10816-10820.
22. Muzio M, Chinnaiyan AM, Kischkel FC et al. FLICE, A novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85: 817-827.
23. Vincenz C, Dixit VM. Fas-associated death domain protein interleukin-1β-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J Biol Chem 1997;272:6578-6583.
24. Atkinson EA, Barry M, Darmon AJ et al. Cytotoxic T lymphocyte-assisted suicide: caspase 3 activation is primarily the result of the direct action of granzyme B. J Biol Chem 1998;273:21261-21266.
25. Darmon AJ, Ley TJ, Nicholson DW, Bleackley RC. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation. J Biol Chem 1996;271:21709-21712.
26. Sarin A, Williams MS, Alexander-Miller MA, Berzofsky JA, Zacharchuk CM, Henkart PA. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 1997;6: 209-215.
27. Yang X, Stennicke HR, Baikun W et al. Granzyme B mimics apical caspases: description of a unified pathway for trans-activation of executioner caspase-3 and -7. J Biol Chem 1998;273:34278-34283.
28. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391:43-50.
29. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;89:175-184.
30. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998;391:96-99.
31. Tang D, Kidd VJ. Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis. J Biol Chem 1998;273: 28549-28552.
32. Cohen GH, Silverton EW, Davies DR. Refined crystal structure of gamma-chymotrypsin at 1.9 Å resolution. Comparison with other pancreatic serine proteases. J Mol Biol 1981;148:449-479.
33. Hedstrom L, Szilagyi L, Rutter WJ. Converting trypsin to chymotrypsin: the role of surface loops. Science 1992;255:1249-1253.
34. Huber R, Bode W. Structural basis of the activation and action of trypsin. Acc Chem Res 1978;11:114-122.
35. Shotton DM, Watson HC. Three-dimensional structure of tosylelastase. Nature 1970;225:811-816.
36. Graf L, Craik CS, Patthy A, Roczniak S, Fletterick RJ, Rutter WJ. Selective alteration of substrate specificity by replacement of aspartic acid-189 with lysine in the binding pocket of trypsin. Biochemistry 1987;26:2616-2623.
37. Graf L, Jancso A, Szilagyi L et al. Electrostatic complementarity within the substrate-binding pocket of trypsin. Proc Natl Acad Sci 1988;85:4961-4965.
38. Murphy ME, Moult J, Bleackley RC, Gershenfeld H, Weissman IL, James MN. Comparative molecular model building of two serine proteinases from cytotoxic T lymphocytes. Proteins 1988;4: 190-204.
39. Poe M, Blake JT, Boulton DA et al. Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity. J Biol Chem 1991;266: 98-103.
40. Caputo A, James MN, Powers JC, Hudig D, Bleackley RC. Conversion of the substrate specificity of mouse proteinase granzyme B. Nat Struct Biol 1994;1:364-367.
41. Caputo A, Garner RS, Winkler U, Hudig D, Bleackley RC. Activation of recombinant murine cytotoxic cell proteinase-1 requires deletion of an amino-terminal dipeptide. J Biol Chem 1993;268:17672-17675.
42. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
43. Quan LT, Caputo A, Bleackley RC, Pickup DJ, Salvesen GS. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J Biol Chem 1995;270:10377-10379.
44. Brunger AT. X-plor: a system for X-ray crystallography and NMR. New Haven: University Press; 1993. p 1-288.
45. Hof P, Mayr I, Huber R et al. The 1.8 Å crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J 1996;15: 5481-5491.
46. Navia MA, McKeever BM, Springer JP et al. Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-Å resolution. Proc Natl Acad Sci 1989;86: 7-11.
47. Thornberry NA, Rano TA, Peterson E et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. J Biol Chem 1997;272:17907-17911.
48. Powers JC, Kam CM, Narasimhan L, Oleksyszyn J, Hernandez MA, Ueda T. Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design. J Cell Biochem 1989;39:33-46.
49. Harris JL, Peterson EP, Hudig D, Thornberry N, Craik CS. Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem 1998;273:27364-27373.
50. Norioka S, Ohta S, Ohara T, Lim SI, Sakiyama F. Identification of three catalytic triad constituents and Asp-225 essential for function of lysine-specific serine protease, Achromobacter protease I. J Biol Chem 1994;269:17025-17029.
51. Perona JJ, Tsu CA, McGrath ME, Craik CS, Fletterick RJ. Relocating a negative charge in the binding pocket of trypsin. J Mol Biol 1993;230:934-949.